Publication
A molecular biophysical approach to diclofenac topical gastrointestinal damage
| dc.contributor.author | Fernandes, Eduarda | |
| dc.contributor.author | Soares, Telma | |
| dc.contributor.author | Gonçalves, Hugo | |
| dc.contributor.author | Bernstorff, Sigrid | |
| dc.contributor.author | Oliveira, Maria Real | |
| dc.contributor.author | Lopes, Carla Martins | |
| dc.contributor.author | Lúcio, Marlene | |
| dc.date.accessioned | 2020-09-22T14:01:28Z | |
| dc.date.available | 2020-09-22T14:01:28Z | |
| dc.date.issued | 2018-10-31 | |
| dc.date.updated | 2020-07-23T09:46:08Z | |
| dc.description.abstract | Diclofenac (DCF), the most widely consumed non-steroidal anti-inflammatory drug (NSAID) worldwide, is associated with adverse typical effects, including gastrointestinal (GI) complications. The present study aims to better understand the topical toxicity induced by DCF using membrane models that mimic the physiological, biophysical, and chemical environments of GI mucosa segments. For this purpose, phospholipidic model systems that mimic the GI protective lining and lipid models of the inner mitochondrial membrane were used together with a wide set of techniques: derivative spectrophotometry to evaluate drug distribution at the membrane; steady-state and time-resolved fluorescence to predict drug location at the membrane; fluorescence anisotropy, differential scanning calorimetry (DSC), dynamic light scattering (DLS), and calcein leakage studies to evaluate the drug-induced disturbance on membrane microviscosity and permeability; and small- and wide-angle X-ray scattering studies (SAXS and WAXS, respectively), to evaluate the effects of DCF at the membrane structure. Results demonstrated that DCF interacts chemically with the phospholipids of the GI protective barrier in a pH-dependent manner and confirmed the DCF location at the lipid headgroup region, as well as DCF’s higher distribution at mitochondrial membrane contact points where the impairment of biophysical properties is consistent with the uncoupling effects reported for this drug. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.3390/ijms19113411 | pt_PT |
| dc.identifier.issn | 1422-0067 | |
| dc.identifier.slug | cv-prod-337467 | |
| dc.identifier.uri | http://hdl.handle.net/10284/8997 | |
| dc.language.iso | eng | pt_PT |
| dc.subject | Diclofenac | pt_PT |
| dc.subject | NSAIDs | pt_PT |
| dc.subject | Derivative spectrophotometry | pt_PT |
| dc.subject | Steady-state and time-resolved fluorescence | pt_PT |
| dc.subject | Steady-state anisotropy | pt_PT |
| dc.subject | DLS | pt_PT |
| dc.subject | DSC | pt_PT |
| dc.subject | SAXS | pt_PT |
| dc.subject | WAXS | pt_PT |
| dc.subject | Gastrointestinal topical toxicity | pt_PT |
| dc.title | A molecular biophysical approach to diclofenac topical gastrointestinal damage | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 26 | pt_PT |
| oaire.citation.issue | 11 | pt_PT |
| oaire.citation.startPage | 1 | pt_PT |
| oaire.citation.title | International Journal of Molecular Sciences | pt_PT |
| oaire.citation.volume | 19 | pt_PT |
| person.familyName | Lopes | |
| person.givenName | Carla | |
| person.identifier.ciencia-id | 901D-160C-633E | |
| person.identifier.orcid | 0000-0001-5080-032X | |
| person.identifier.rid | M-4689-2016 | |
| person.identifier.scopus-author-id | 26649517700 | |
| rcaap.cv.cienciaid | 901D-160C-633E | Carla Martins Lopes | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | d2a48cfe-9258-4916-99be-bbcb710f6605 | |
| relation.isAuthorOfPublication.latestForDiscovery | d2a48cfe-9258-4916-99be-bbcb710f6605 |